Aceto

New York, United States Founded: 1947 • Age: 79 yrs Listed
APIs, intermediates, formulations, and chemicals are manufactured and distributed.

About Aceto

Aceto is a publicly listed company based in New York (United States) founded in 1947. APIs, intermediates, formulations, and chemicals are manufactured and distributed. Aceto has completed 8 acquisitions, including A&C, A&C Bio Buffer and Biotron Laboratories. Its Indian entity Aceto Pharma (India) Private Limited reported revenue of ₹341 Cr. Aceto offers products and services including Analytical Services, GMP Contract Manufacturing, and R&D Services. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Asymchem, Aptuit and Continuus Pharma; 2 of its 3 listed competitors have raised funding.

Company details

Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.

Key Metrics
  • Indian entity revenue
    ₹341 Cr

    FY 2025 · 0% YoY

  • Indian entity net profit
    ₹69.97 Cr

    FY 2025 · 21% margin

  • Indian entity EBITDA
    ₹103 Cr

    FY 2025 · 30% margin

  • Latest Funding Round
    $144M (USD), Post-IPO

    Nov 2015

  • Investments & Acquisitions
    A&C

    & 7 more

Products & Services of Aceto

Aceto offers a comprehensive portfolio of products and services, including Analytical Services, GMP Contract Manufacturing, and R&D Services.

Analytical Services
Testing

Offers testing for raw materials in multiple industries

GMP Contract Manufacturing
Manufacturing

Provides contract production of APIs and intermediates

R&D Services
Development

Delivers custom research and scale-up for ingredient solutions

Apps and channels of Aceto

its YouTube channel Actylis has 66 subscribers and 10 videos.

Actylis
YouTube 66 subscribers 10 videos Autos & Vehicles
Open channel

Videos from Aceto

The most watched videos on Aceto's YouTube channel, Actylis (66 subscribers). Click a video to play it here.

Actylis & Companies History Timeline
347 views
Actylis Animation - Pharma&Biopharma
203 views
ABBC1 - AB BIOTEK - Long version
187 views
New Manufacturing Site for Advanced Intermediate and GMP Clinical & Commercial APIs
186 views

More on Actylis.

Funding Insights of Aceto

  • Total Rounds 1
  • Last Round Post-IPO — $144M
  • First Round $144M

    (Nov 2015)

All 1 funding rounds of Aceto with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2015$144MPost-IPO––
–

Board of directors of Aceto Pharma (India) Private Limited (Aceto)

Aceto Pharma (India) Private Limited is the primary company behind Aceto. The board of Aceto Pharma (India) Private Limited currently have 4 directors; the longest-serving is Varun Vijay Rao, appointed in 2020. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Varun Vijay Rao
DIN 02509615
Director02 Nov 20206 yrsAceto Pharma (India) Private Limited
Arpit Chandrakant Butala
DIN 10348219
Director06 Feb 20242 yrs 9 moAceto Pharma (India) Private Limited
Raj Kumar Gupta
DIN 11039904
Additional Director09 Apr 20251 yr 7 moAceto Pharma (India) Private Limited
Eric Gaertner
DIN 11376375
Additional Director11 Nov 20251 yrAceto Pharma (India) Private Limited

People of Aceto

73 people are tracked at Aceto (33 in leadership, 4 in board & advisors, 36 in team).

NameRoleGroup
Rajesh Patel
Business Development Director - CosmeticLeadership
Larry Fertel
Research DirectorLeadership
Director Quality & Regulatory- APACLeadership
Amit Maheshwari
President, FinarLeadership
James Steele
Chief Financial OfficerLeadership
Jean-Pierre Darriot
Head Of Finance EuropeLeadership
Jeremiah Marsden
President, Cascade & Head of Global R&DLeadership
Eric Escobar
Vice President Global Pharma SalesLeadership
Julie Sternberg
Sales Director Strategic Accounts Pharma EuropeLeadership
Scott Thomson
Chief Executive OfficerLeadership
Ryan Kinkaid
Associate Director, New Business Development At ActylisLeadership
John Elliot Simpkins
Chief Human Resources OfficerLeadership
Lauren Seufert
Chief Strategy OfficerLeadership
Tim Quinn
Vice President & General Manager PharmaceuticalsLeadership
Kristin Decarolis
Director, Financial Reporting And ComplianceLeadership
Prasanna H M
Head Of Fp&a, Data OfficeLeadership
Jeffrey Hatch
Associate Director, Business Development At ActylisLeadership
Stephanie Scroggie
Vice President / Corporate ControllerLeadership
Penny Lipe
Vice President, Financial Planning & AnalysisLeadership
Jessie Pannu
Director Of Quality And Regulatory AffairsLeadership

53 more people are available in the full profile.

Premium access

Complete people profiles for Aceto

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Aceto

Aceto is a publicly listed company on the NASDAQ with ticker symbol ACET in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date13 Jan 1978
  • Listed onNASDAQ: ACET
  • Listed entityAdicet Bio, Inc.
  • Exchange sectorHealth technology

Financials of Aceto

Figures of Aceto Pharma (India) Private Limited, the primary company behind Aceto, for FY 2025. Revenue was ₹341 Cr (0% year on year). Net profit was ₹69.97 Cr (21% margin). EBITDA was ₹103 Cr (30% margin). Revenue has grown at a compounded annual rate of +5% over three years and +117% over five years.

  • ₹341 CrRevenue · FY 2025 · 0% YoY
  • ₹69.97 CrNet profit · 21% margin
  • ₹103 CrEBITDA · 30% margin
  • ₹101 CrPaid-up capital
  • 28Employees (provident fund records)
  • +5%Revenue CAGR, 3 years
  • +117%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aceto Pharma (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Aceto

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aceto

Aceto has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include A&C, A&C Bio Buffer and Biotron Laboratories.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Mineral ingredient consulting services are provided to industry clients.
talusminerals.comOgden, United States2014Mar 2022••••
Laboratory focused on developing chelated mineral products
biotronlabs.comCenterville, United States1979Mar 2022••••
GMP biological buffers, cleaning solutions, and related products are manufactured.
acbiobuffer.comLimerick, Ireland2018Oct 2021••••
Synthetic, analytical, and API manufacturing services are provided.
cascadechemistry.comEugene, United States1980Jun 2021••••
Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals
finarchemicals.comAhmedabad, India1998May 2021••••
APIs and pharmaceutical intermediates are manufactured by A&C.
acggp.comMontreal, Canada1966Apr 2021••••
Chemicals for multiple sectors are manufactured through focused R&D.
islechem.comGrand Island, United States2001Dec 2020••••
Pharmaceutical, agrochemical, aroma, and polymer chemicals are manufactured and supplied.
syntor.co.ukRuncorn, United Kingdom2004Apr 2020••••
Premium access

Complete acquisition details for Aceto

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Aceto

11 dated milestones of Aceto across 75 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aceto is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $144.0M.
  4. Acquisition Acquires Syntor.
  5. Acquisition Acquires IsleChem.
  6. Acquisition Acquires A&C.
  7. Acquisition Acquires Finar.
  8. Acquisition Acquires Cascade Chemistry.
  9. Acquisition Acquires A&C Bio Buffer.
  10. Acquisition Acquires Talus Mineral.
  11. Acquisition Acquires Biotron Laboratories.

Competitors of Aceto

Aceto has 3 listed competitors in our database, 2 of them funded. They include Asymchem, Aptuit and Continuus Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asymchem.com1995Morrisville, United States48
APIs and peptides are developed and manufactured by Asymchem.
aptuit.com2004Greenwich, United States$14.23M
Contract research and development services for small molecules are offered.
continuuspharma.com2012Woburn, United States$7.73M47
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development
Premium access

Detailed competitors of Aceto

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aceto

Websites that share an audience with Aceto (aceto.com).

Similar websites

Websites whose visitors overlap most with Aceto. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
amerchem.com
amerchem.com
100%
–
matrix-marketing.ch
matrix-marketing.ch
100%
–
changje.com
changje.com
100%
–
sundry-tech.com
sundry-tech.com
100%
–
rollechim.com
rollechim.com
84%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 30 similar websites and full traffic analytics for Aceto

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 30 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Aceto (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aceto

Premium access

Complete news archive for Aceto

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aceto

Aceto was founded in 1947 and raised its 1st funding round 68 years after it was founded.

Aceto is headquartered in New York, United States. It is registered at New York, New York, United States.

The primary company behind Aceto, Aceto Pharma (India) Private Limited, reported revenue of ₹341 Cr for FY 2025, down 0% year on year.

Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.

Aceto's top competitors include Asymchem, Aptuit and Continuus Pharma.

Aceto offers Analytical Services, GMP Contract Manufacturing, and R&D Services.

Yes, Aceto is publicly traded on NASDAQ under the ticker symbol ACET.

Aceto has made 8 acquisitions, including A&C, A&C Bio Buffer, and Biotron Laboratories.

Aceto operates through Aceto Pharma (India) Private Limited.

The legal entities of Aceto currently have 5 directors, including Arpit Chandrakant Butala, Varun Vijay Rao, Madhaviben Bhaskarbhai Dave and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available